Royce & Associates’s Tvardi Therapeutics, Inc. Common Stock TVRD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | – | Sell |
-5,619
| Closed | -$340K | – | 948 |
|
|
2023
Q3 | $340K | Hold |
5,619
| – | – | ﹤0.01% | 841 |
|
|
2023
Q2 | $573K | Hold |
5,619
| – | – | 0.01% | 823 |
|
|
2023
Q1 | $993K | Hold |
5,619
| – | – | 0.01% | 763 |
|
|
2022
Q4 | $2.17M | Sell |
5,619
-330
| -6% | -$128K | 0.02% | 632 |
|
|
2022
Q3 | $2.01M | Buy |
5,949
+3,156
| +113% | +$1.06M | 0.02% | 625 |
|
|
2022
Q2 | $918K | Sell |
2,793
-307
| -10% | -$101K | 0.01% | 761 |
|
|
2022
Q1 | $1.36M | Buy |
3,100
+2,733
| +745% | +$1.2M | 0.01% | 775 |
|
|
2021
Q4 | $161K | Sell |
367
-54
| -13% | -$23.7K | ﹤0.01% | 950 |
|
|
2021
Q3 | $234K | Buy |
+421
| New | +$234K | ﹤0.01% | 962 |
|